Replies to post #1687 on Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

ABBV's Mavyret weekly NRx market share of the HCV market is at 52% (from 49% the previous week) for the week ending 8/24.

It seems like ENTA goes down no matter what.